neurodevelopmental disorders

Fetal Reduction in Triplet Pregnancies Significantly Reduces Neurodevelopmental Risks, Study Finds

By MedXY 04/23/2026

A nationwide cohort study reveals that fetal reduction from triplets to twins lowers the long-term risk of neurodevelopmental disorders in surviving children compared to non-reduced pregnancies.

Clinical Updates Diabetes & Endocrinology Neurology news

Distinctive Endocrine Profiles and Hyperphagia in Rare Genetic Neurodevelopmental Disorders: Beyond the Prader-Willi Paradigm

By MedXY 03/11/2026

This review synthesizes findings from a national multicenter study identifying that hyperghrelinemia is a specific biomarker for Prader-Willi Syndrome, whereas other rare neurodevelopmental disorders exhibit normal ghrelin levels despite severe hyperphagia and significant caregiver burden.

Neurology news Pediatrics

The Mortality Gap in Neurodevelopmental Care: Why Young Adults with ASD, ID, and CP Face Higher Risks

By MedXY 02/10/2026

A landmark study using CDC ADDM Network data reveals significantly elevated mortality risks for young adults with autism, intellectual disability, and cerebral palsy, highlighting a critical need for improved transition-of-care strategies and better clinical surveillance.

Cardiology news OB/GYN & Women's Health

Maternal Pre-existing Atherosclerotic Cardiovascular Disease: A Hidden Risk Factor for Neonatal Health and Long-term Neurodevelopment

By MedXY 12/25/2025

A nationwide cohort study demonstrates that maternal pre-existing ASCVD is independently associated with an increased risk of neonatal complications and long-term neurodevelopmental disorders, persisting regardless of adverse pregnancy outcomes.

Cardiology Diabetes & Endocrinology Neurology news Specialties

Sulforaphane in Clinical Medicine: A Decade of Research Progress and Therapeutic Potential

By MedXY 08/24/2025

This review synthesizes 10 years of sulforaphane (SFN) research, highlighting its pharmacology, clinical trial outcomes, and emerging therapeutic prospects across cancer, metabolic, renal, neurodevelopmental, and cardiovascular disorders.

Clinical Updates Medical News Pediatrics Public Health Specialties

Aluminum-Adjuvanted Vaccines in Early Childhood and Risk of Chronic Autoimmune, Allergic, and Neurodevelopmental Disorders: Insights from a Danish Nationwide Cohort Study

By MedXY 07/31/2025

A comprehensive Danish cohort study finds no evidence linking early childhood aluminum-adsorbed vaccines to increased risks of autoimmune, allergic, or neurodevelopmental disorders, supporting vaccine safety.